Catalyst Wire Dossier Catalyst Wire Dossier

Glaucoma therapy (study agent)

· Alcon Research Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glaucoma therapy (study agent), covering 2016-11-18 to 2016-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

See pricing